ACSL3 and metabolic dysfunction-associated steatotic liver disease: These results suggested that ACSL3 expression was elevated in NAFLD and HCC and promotes the progression from NAFLD to HCC, while high expression of ACSL3 was positively correlated with poor prognosis of HCC patients.